Characteristics Associated with Adding Insulin in Type 2 Diabetes in the Glycemia Reduction Approaches in Diabetes (GRADE) Study

被引：0
|
作者：
Martin, Catherine
Hollander, Priscilla A.
Krause-Steinrauf, Heidi
Kazemi, Erin
Butera, Nicole M.
Ahmann, Andrew
Falck-Ytter, Corinna
Fattaleh, Basma
Johnson, Mary L.
Killean, Tina
Lagari, Violet
Larkin, Mary E.
Legowski, Elizabeth
Rasouli, Neda
Willis, Holly
机构：
来源：
DIABETES | 2022年 / 71卷
关键词：
D O I：
10.2337/db22-220-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
220-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [31] VARIABILITY OF GLYCEMIA IN PATIENTS WITH 2 TYPE DIABETES
    Sharafetdinov, K.
    Plotnikova, O.
    Pilipenko, V.
    Alexeeva, R.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2020, 22 : A219 - A219
  • [32] Comparative Effects of Randomized Second-line Therapy for Type 2 Diabetes on a Composite Outcome Incorporating Glycemic Control, Body Weight, and Hypoglycemia: An Analysis of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
    Kirkman, M. Sue
    Tripputi, Mark
    Krause-Steinrauf, Heidi
    Bebu, Ionut
    AbouAssi, Hiba
    Burch, Henry
    Duran-Valdez, Elizabeth
    Florez, Hermes
    Garvey, W. Timothy
    Hsia, Daniel S.
    Salam, Maamoun
    Pop-Busui, Rodica
    DIABETES CARE, 2024, 47 (04) : 594 - 602
  • [33] Initial management of glycemia in type 2 diabetes
    Banarer, S
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (08): : 760 - 760
  • [34] Glycemia and cardiovascular diseases in type 2 diabetes
    Skyler, J. S.
    JOURNAL OF INTERNAL MEDICINE, 2010, 268 (05) : 468 - 470
  • [35] Clinical Factors Associated with Insulin Regression When Adding Tirzepatide in Basal Insulin-Treated Type 2 Diabetes
    Wysham, Carol H.
    Rosenstock, Julio
    Tofe, Santiago
    Thieu, Vivian
    Kiljanski, Jacek I.
    Lee, Clare
    Wang, Hui
    Patel, Hiren
    DIABETES, 2024, 73
  • [36] Use of comprehensive recruitment strategies in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE) multi-center clinical trial
    Cherrington, Andrea L.
    Krause-Steinrauf, Heidi
    Aroda, Vanita
    Buse, John B.
    Fattaleh, Basma
    Fortmann, Stephen P.
    Hall, Stephanie
    Hox, Sophia H.
    Kuhn, Alexander
    Killean, Tina
    Loveland, Amy
    Phillips, Lawrence S.
    Jackson, Analyn Uy
    Waltje, Andrea
    McKee, M. Diane
    CLINICAL TRIALS, 2023, 20 (05) : 546 - 558
  • [37] Technosphere Insulin Effectively Controls Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus
    Zisser, Howard
    Jovanovic, Lois
    Markova, Kateryna
    Petrucci, Richard
    Boss, Anders
    Richardson, Peter
    Mann, Alfred
    DIABETES TECHNOLOGY & THERAPEUTICS, 2012, 14 (11) : 997 - 1001
  • [38] Impact of Insulin Sensitivity and β-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy
    Utzschneider, Kristina M.
    Younes, Naji
    Butera, Nicole M.
    Balasubramanyam, Ashok
    Bergenstal, Richard M.
    Barzilay, Joshua
    DeSouza, Cyrus
    DeFronzo, Ralph A.
    Elasy, Tom
    Krakoff, Jonathan
    Kahn, Steven E.
    Rasouli, Neda
    Valencia, Willy M.
    Sivitz, William I.
    DIABETES CARE, 2024, 47 (04) : 571 - 579
  • [39] Advantages of adding metformin to multiple dose insulin therapy in type 2 diabetes
    Bergenstal, R
    Johnson, M
    Whipple, D
    Noller, D
    Boyce, K
    Roth, L
    Upham, P
    Fish, L
    Debold, R
    DIABETES, 1998, 47 : A89 - A89
  • [40] Glycemia reduction in type 2 diabetes-Hypoglycemia outcomes: A randomized clinical trial
    Seaquist, Elizabeth R.
    Phillips, Lawrence S.
    Ghosh, Alokananda
    Baker, Chelsea
    Bergenstal, Richard M.
    Crandall, Jill P.
    Goland, Robin S.
    Gramzinski, Michaela R.
    Hox, Sophia H.
    Hsia, Daniel S.
    Johnson, Mary L.
    Lachin, John M.
    Raskin, Philip
    Valencia, Willy M.
    Waltje, Andrea H.
    Younes, Naji
    PLOS ONE, 2024, 19 (11):
12345